8-K
filed April 28, 2023, 7:59 PM ET
ticker WST
CIK 0000105770
other
confidence high
sentiment neutral
materiality 0.15
West Pharmaceutical shareholders elect all directors, approve say-on-pay, reject fair elections proposal
WEST PHARMACEUTICAL SERVICES INC
- All 11 director nominees elected; each received >60M votes for with minimal against.
- Advisory say-on-pay approved with 95.3% of votes cast in favor (62.3M for).
- Ratification of PwC as auditor approved with 92.2% of votes cast (62.2M for).
- Advisory vote on frequency: 1 year selected with 98.7% of votes cast (64.5M for 1 year).
- Shareholder proposal on fair elections rejected: 89.2% of votes cast against (58.2M against).
Key facts
Extracted from this filing and checked against the source text.
Shareholder Votes
SEC 8-K Item 5.07
confidence 1.0
WEST PHARMACEUTICAL SERVICES INC shareholders approved Advisory vote on frequency of votes on executive officer compensation at the 2023-04-25 meeting.
- Proposal
- say on pay frequency
- Outcome
- passed
- Meeting
- 2023-04-25
Exact text from the filing
Proposal 4: Our shareholders approved, on an advisory basis, the frequency of votes on executive officer compensation by the following vote: 1 Year 2 Years 3 Years Abstain 64,486,696 15,575 838,359 33,838
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 1.0
WEST PHARMACEUTICAL SERVICES INC shareholders approved Ratification of PricewaterhouseCoopers LLP as independent registered public accounting firm at the 2023-04-25 meeting.
- Proposal
- auditor ratification
- Outcome
- passed
- Meeting
- 2023-04-25
Exact text from the filing
Proposal 3: Our shareholders ratified the selection of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the 2023 fiscal year by the following vote: For Against Abstain 62,221,862 5,198,468 24,451
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 1.0
WEST PHARMACEUTICAL SERVICES INC shareholders approved Election of directors at the 2023-04-25 meeting.
- Proposal
- director election
- Outcome
- passed
- Meeting
- 2023-04-25
Exact text from the filing
Proposal 1: Our shareholders elected the following directors to serve on our Board until the 2024 Annual Meeting of Shareholders by the following vote: Name For Against Abstain Broker Non-Votes Mark A. Buthman 64,658,097 113,624 602,747 2,070,313 William F. Feehery 55,002,437 2,878,944 7,493,087 2,070,313 Robert F. Friel 62,935,621 969,217 1,469,630 2,070,313 Eric M. Green 60,170,150 281,325 4,922,993 2,070,313 Thomas W. Hofmann 61,851,061 462,430 3,060,977 2,070,313 Molly E. Joseph 64,827,643 63,822 483,003 2,070,313 Deborah L. V. Keller 62,842,349 936,277 1,595,842 2,070,313 Myla P. Lai-Goldman 65,133,007 69,433 172,028 2,070,313 Stephen H. Lockhart 65,094,280 51,507 228,681 2,070,313 Douglas A. Michels 62,752,334 441,377 2,180,757 2,070,313 Paolo Pucci 62,937,309 968,520 1,468,639 2,070,313
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 1.0
WEST PHARMACEUTICAL SERVICES INC shareholders approved Advisory vote on named executive officer compensation at the 2023-04-25 meeting.
- Proposal
- say on pay
- Outcome
- passed
- Meeting
- 2023-04-25
Exact text from the filing
Proposal 2: Our shareholders approved, on an advisory basis, our named executive officer compensation by the following vote: For Against Abstain Broker Non-Votes 62,330,606 2,954,865 88,997 2,070,313
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 1.0
WEST PHARMACEUTICAL SERVICES INC shareholders rejected Shareholder proposal regarding fair elections at the 2023-04-25 meeting.
- Outcome
- failed
- Meeting
- 2023-04-25
Exact text from the filing
Proposal 5: Our shareholders rejected the shareholder proposal regarding fair elections by the following vote: For Against Abstain Broker Non-Votes 7,047,212 58,183,766 143,490 2,070,313
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.